{
  "meta": {
    "title": "Neoplasia_Part_2",
    "url": "https://brainandscalpel.vercel.app/neoplasia-part-2-c2472614.html",
    "scrapedAt": "2025-11-30T11:19:16.323Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Activation of growth promoting oncogenes</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Inactivation of tumour suppressor genes</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Alterations in genes that regulate apoptosis</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Mutations in genome of somatic cells is likely to lead to:</span></p>",
      "unique_key": "DT1167989",
      "question_audio": null,
      "question_video": null,
      "map_id": 1167989,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Cancer genes fall into one of four major functional classes:\n<ul>\n<li>The growth promoting proto-oncogenes,</li>\n<li>The growth inhibiting tumour suppressor genes,</li>\n<li>Genes that regulates apoptosis</li>\n<li>The genes involved in DNA repair.</li>\n</ul>\n</li>\n<li>If a mutation occurs in a somatic cell of an organism, it will be present in all descendants of this cell within the same organism. The accumulation of certain mutations over generations of somatic cells is part of the process of malignant transformation, from normal cell to cancer cell.</li>\n</ul>",
      "correct_choice_id": 4,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyclins</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">KRAS</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">EGFR</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">PDGF</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a GTP binding protein?</span></p>",
      "unique_key": "DT1167998",
      "question_audio": null,
      "question_video": null,
      "map_id": 1167998,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>RAS most commonly is activated by point mutations in amino acid residues that are either within the GTP binding pocket or in the enzymatic region that carries out GTP hydrolysis.</li>\n<li>The KRAS gene(Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) is an oncogene that encodes a small GTPase transductor protein called KRAS. KRAS is involved in the regulation of cell division as a result of its ability to relay external signals to the cell nucleus.</li>\n<li>KRAS is a member of the RAS family of proto-oncogenes and encodes a GTP-binding protein that acts as a molecular switch in signal transduction pathways.</li>\n<li>KRAS belongs to the small GTPase family.</li>\n<li>It cycles between:\n<ul>\n<li>Active GTP-bound form (on)</li>\n<li>Inactive GDP-bound form (off)</li>\n</ul>\n</li>\n<li>Once activated by upstream signals (like receptor tyrosine kinases), KRAS activates downstream pathways such as:\n<ul>\n<li>MAPK/ERK</li>\n<li>PI3K/AKT</li>\n</ul>\n</li>\n<li>Mutations in KRAS (commonly in pancreatic, colon, and lung cancers) lead to constitutive GTP binding, meaning KRAS is permanently \"on,\" promoting uncontrolled cell proliferation.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<ul>\n<li><strong>Cyclins(Option A): </strong>Cyclins are regulatory proteins that control the cell cycle by activating cyclin-dependent kinases (CDKs).They do not bind GTP. Function is cell cycle regulation, not signal transduction via GTP.</li>\n<li><strong>EGFR (Epidermal Growth Factor Receptor)(Option C): </strong>EGFR is a receptor tyrosine kinase (RTK). It binds EGF and activates downstream signaling via autophosphorylation, not GTP-binding.</li>\n<li>EGFR activates RAS, but it does not bind GTP itself.</li>\n<li><strong>PDGF (Platelet-Derived Growth Factor)(Option D): </strong>PDGF is a ligand (growth factor) that binds to its receptor (a receptor tyrosine kinase).</li>\n<li>It initiates signaling cascades, including the RAS pathway.</li>\n</ul>",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">p21</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">p53</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">p57</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">p27</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a cell cycle regulator</span></p>",
      "unique_key": "DT1168002",
      "question_audio": null,
      "question_video": null,
      "map_id": 1168002,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202403260713e919-e7c6-47d5-a4c1-bb6d4dcd9f3c.jpg.jpg\">\n<ul>\n<li>Cyclin D-CDK4, cyclin D-CDK6 and cyclin E-CDK2 regulate the G1-to-S transition by phosphorylating the Rb protein(pRb).</li>\n<li>Cyclin A-CDK2 and cyclin A-CDK1 are active in the S phase.</li>\n<li>Cyclin B-CDK1 is essential for the G2-to-M transition.</li>\n<li>Two families of CDK inhibitors can block activity of CDKs and progression through the cell cycle.</li>\n<li>The so-called <strong>\"INK4 inhibitors\",</strong>composed of p16, p15, p18 and p19, act on cyclin D-CDK4 and cyclin D-CDK6.</li>\n<li>The other family of these inhibitors p21, p27 and p57, can inhibit all CDKs.</li>\n</ul>",
      "correct_choice_id": 22,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Biochemical indicators of the presence of a tumour</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">DNA microarrays</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Non coding RNAs</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Tumour suppressor genes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements defines the tumour marker?</span></p>",
      "unique_key": "DT1168009",
      "question_audio": null,
      "question_video": null,
      "map_id": 1168009,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Tumor markers are biochemical indicators of the presence of a tumor.</li>\n<li>They are usually substances produced by the tumor itself or sometimes by the host in response to tumor growth, and they can be detected in blood, urine, or tissue samples.</li>\n<li>These markers are often proteins, hormones, enzymes, or antigens, and are used primarily for:\n<ul>\n<li>Monitoring <strong>response to treatment</strong></li>\n<li>Detecting <strong>recurrence</strong></li>\n<li>Sometimes aiding in <strong>diagnosis and prognosis</strong></li>\n</ul>\n</li>\n</ul>",
      "correct_choice_id": 31,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Follicular carcinoma of thyroid</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Papillary carcinoma of the thyroid</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Medullary carcinoma of the thyroid</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Poorly differentiated carcinoma of thyroid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with a thyroid nodule, and laboratory investigations reveal markedly elevated serum calcitonin levels. This finding is most characteristic of which of the following thyroid malignancies?</span></p>",
      "unique_key": "DT1168013",
      "question_audio": null,
      "question_video": null,
      "map_id": 1168013,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/20231216de02473f-7ffa-47e4-b285-4d2a517894a2.png\">\n<p>Abundant deposition of amyloid, homogenous extra cellular material derived</p>\n<p>From calcitonin</p>\n<ul>\n<li>Medullary carcinomas of the thyroid are neuroendocrine tumours derived from the parafollicular cells or C cells of the thyroid.</li>\n<li>These cells normally secrete calcitonin, a hormone that helps regulate calcium levels.</li>\n<li>There is overproduction of calcitonin, which serves as a tumor marker.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<ul>\n<li><strong>Follicular carcinoma of the thyroid(Option A): </strong>It Arises from follicular epithelial cells, not parafollicular C cells.Typically produces thyroglobulin, not calcitonin.</li>\n<li>Serum thyroglobulin may be used as a tumor marker for recurrence or metastasis.</li>\n<li><strong>Papillary carcinoma of the thyroid(Option B): </strong>It is the most common thyroid cancer.Arises from follicular epithelial cells.</li>\n<li>Associated with RET/PTC rearrangements and BRAF mutations.</li>\n<li>Diagnosis is based on characteristic nuclear features (Orphan Annie eyes, nuclear grooves), not serum markers like calcitonin.</li>\n<li><strong>Poorly differentiated carcinoma of the thyroid(Option D): </strong>It is an intermediate form between well-differentiated (e.g., papillary, follicular) and undifferentiated (anaplastic) carcinoma.</li>\n<li>May produce <strong>thyroglobulin</strong>, but not calcitonin.</li>\n</ul>",
      "correct_choice_id": 43,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Classify tumours</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Predict metastatic potential</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Predict Prognosis</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What are the uses of DNA Microarrays?</span></p>",
      "unique_key": "DT1168033",
      "question_audio": null,
      "question_video": null,
      "map_id": 1168033,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The most common method for large-scale analysis of RNA expression in use in research laboratories has been based on DNA microarrays.</li>\n<li>DNA microarrays help in identifying <strong>distinct molecular subtypes</strong> of tumors based on gene expression profiles. This is especially useful when:\n<ul>\n<li>Tumors have similar histology but different gene expression (e.g., types of <strong>lymphomas</strong> or <strong>breast cancer</strong>).</li>\n<li>The goal is to tailor treatment based on molecular classification.</li>\n</ul>\n</li>\n<li>DNA microarray analysis helps as the bacterial genomic DNA often outlasts the viability of the bacteria and a diagnosis can be made using a small amount of DNA, as opposed to the large numbers of bacteria needed for culture.</li>\n</ul>",
      "correct_choice_id": 51,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Diagnosis of malignant neoplasm</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Detection of minimal residual disease</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Diagnosis of hereditary predisposition to cancer</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Molecular diagnosis is used for which of the following?</span></p>",
      "unique_key": "DT1168035",
      "question_audio": null,
      "question_video": null,
      "map_id": 1168035,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Molecular diagnosis is used for diagnosis of malignancy, prognosis and behaviour, detection of minimal residual disease, diagnosis of hereditary predisposition to cancer and therapeutic decision-making.</li>\n<li>Molecular diagnostics are a battery of widely applied, powerful and sensitive techniques used to identify biologic markers in a genome and proteome by detecting bacterial genes(with PCR-based techniques) and measuring expressed bacterial infection specific proteins(with enzyme-linked immunosorbent assay[ELISA] and proteomics).</li>\n</ul>",
      "correct_choice_id": 64,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Only i, ii and iii are correct</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Only i and iii are correct</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Only ii and iv are correct</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Only iv is correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is/are true in the context of stage of a tumour?<br>i. The degree to which the tumour has spread locally<br>ii. The level of lymph node involvement if any<br>iii. Presence or absence of metastasis<br>iv. The degree of differentiation or Anaplasia</span></p>",
      "unique_key": "DT1168044",
      "question_audio": null,
      "question_video": null,
      "map_id": 1168044,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation</strong></p>\n<ul>\n<li>The staging of solid cancers is based on the size of the primary lesion, its extent of spread to regional lymph nodes and the presence or absence of blood borne metastases.</li>\n<li>The degree of differentiation or anaplasia refers to tumor grade, not stage.Grading of a cancer is based on the degree of differentiation of the tumour cells and in some cancers, the number of mitoses and the presence of certain architectural features.(<strong>statement iv ruled out)</strong></li>\n</ul>",
      "correct_choice_id": 71,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Only i, ii and iii are correct</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Only i and iii are correct</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Only ii and iv are correct</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Only iv is correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following growth factors is associated with cancer cachexia?<br>i. PDGF<br>ii. EGF<br>iii. VEGF<br>iv. TNF</span></p>",
      "unique_key": "DT1168051",
      "question_audio": null,
      "question_video": null,
      "map_id": 1168051,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>It is suspected that TNF and other cytokines produced by macrophages in response to tumour cells or by the tumour cells themselves mediate cachexia.</li>\n<li>TNF suppresses appetite and inhibits the action of lipoprotein lipase, preventing the release of free fatty acids from lipoproteins.</li>\n<li>TNF-&alpha; is chiefly secreted by macrophages in response to stimuli for the induction of systemic inflammation. The binding of the ligand TNF-&alpha; to the TNF receptor(TNFR1) initiates the pro-inflammatory and pro-apoptotic signaling cascades.</li>\n</ul>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Only i, ii and iii are correct</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Only i and iii are correct</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Only ii and iv are correct</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Only iv is correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The greatest utility of frozen section lies in:<br>i. Confirmation of primary diagnosis made on biopsy<br>ii. For immunohistochemistry<br>iii. For Flow cytometry<br>iv. Assessment of surgical margins</span></p>",
      "unique_key": "DT1168054",
      "question_audio": null,
      "question_video": null,
      "map_id": 1168054,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Frozen section is a rapid intraoperative diagnostic technique where a tissue specimen is quickly frozen, sectioned, stained, and examined by a pathologist usually while the patient is still on the operating table.</li>\n<li>Requesting frozen section diagnosis is sometimes desirable, as for example, in determining the nature of a mass lesion or in evaluating the regional lymph nodes in a patient with cancer for metastasis.</li>\n<li>Freezing tissue disrupts cell viability, making it unsuitable for flow cytometry.<strong>(Statement iii ruled out)</strong></li>\n<li>For the confirmation of primary diagnosis, histochemical processing and staining is required.<strong>(Statement i ruled out)</strong></li>\n<li>Formalin-fixed paraffin-embedded (FFPE) tissue is the standard for IHC.Antigen preservation and morphology are better in FFPE.<strong>(Statement ii is ruled out)</strong></li>\n</ul>",
      "correct_choice_id": 94,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">&alpha; Fetoprotein</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Carcinoembryonic antigen(CEA)</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Chloro acetate esterase(CAE)</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Human chorionic gonadotropin(hCG)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following marker is most useful for future follow-up of a patient with colon cancer?</span></p>",
      "unique_key": "DT1168058",
      "question_audio": null,
      "question_video": null,
      "map_id": 1168058,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Carcinoembryonic antigen (CEA) is a glycoprotein associated with many cancers including adenocarcinomas of the colon, pancreas, lung, stomach and breast.It is used clinically to follow up patients with certain malignancies, such as colon cancer, and to evaluate them for recurrence or metastases.</li>\n<li>Tumor markers are a diverse group of biochemical substances associated with the presence of some tumors. These tumor markers include hormones, oncofetal antigens, isozymes, proteins, mucins and glycoproteins .</li>\n<li>Prostate-specific antigen(PSA) and prostatic acid phosphatase(PAP) are associated with cancer of the prostate.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<ul>\n<li><strong>Alpha fetoprotein(AFP)(Option A): </strong>It is a glycoprotein synthesized by the yolk sac and the fetal liver and is associated with yolk sac tumors of the testes and liver cell carcinomas.</li>\n<li><strong>Chloroacetate esterase(CAE)(OptionC):</strong>, not to be confused with CEA, is a histochemical stain used in the differentiation of acute leukemias. It is not considered to be a tumor marker.</li>\n<li><strong>Human chorionic gonadotropin(hCG)(Option D):</strong>Tumor marker used in:\n<ul>\n<li>Choriocarcinoma</li>\n<li>Germ cell tumors (especially testicular cancer)</li>\n</ul>\n</li>\n<li>It is a hormone, made up of an alpha and beta subunit, that is produced by the placenta and normally is only measurable during pregnancy.</li>\n</ul>",
      "correct_choice_id": 102,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Diamino benzidine(DAB)</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">FITC</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Phycoerythrin</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Benzidine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A histopathological image shows a tissue section with cells demonstrating a distinct brown-colored cytoplasmic staining, indicative of a positive immunohistochemical reaction. Which of the following chromogens is most likely responsible for this brown staining?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/2023121684fe9e98-51aa-4d22-9737-5264c6c14082.png\"></span></p>",
      "unique_key": "DT1168063",
      "question_audio": null,
      "question_video": null,
      "map_id": 1168063,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>DAB (3, 3&prime;-Diaminobenzidine) is a derivative of benzene. It is most often used in immunohistochemical(IHC) staining as a chromogen. It is also used in <em>in situ</em>hybridization(ISH).</li>\n<li>In DAB staining, DAB is oxidized by hydrogen peroxide in a reaction typically catalyzed by horseradish peroxidase(HRP). The oxidized DAB forms a brown precipitate, at the location of the HRP, which can be visualized using light microscopy.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<ul>\n<li><strong>FITC (Fluorescein isothiocyanate)(Option B): </strong>It is not a chromogen, but a fluorophore (fluorescent dye). It emits green fluorescence when excited with blue light (~495 nm)Used in immunofluorescence,Requires a fluorescence microscope.</li>\n<li><strong>Phycoerythrin(Option C): </strong>It is a fluorescent dye (fluorophore).Derived from red algae and emits red-orange fluorescenceUsed in flow cytometry and immunofluorescence, not in IHC that produces brown color</li>\n<li><strong>Benzidine(Option D):</strong> It was used as a peroxidase substrate like DAB.Produced a blue color, not brownHighly carcinogenic, so it is no longer used in clinical labs</li>\n</ul>",
      "correct_choice_id": 111,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Protein kinase inhibitor</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Growth factor inhibitor</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">GTPase</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Transcription activator</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the function of the MYC gene?</span></p>",
      "unique_key": "DT1168073",
      "question_audio": null,
      "question_video": null,
      "map_id": 1168073,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>A host of oncoproteins, including products of the MYC, MYB, JUN, FOS and REL oncogenes, function as transcription factors that regulate the expression of growth-promoting genes, such as cyclins.Of these, MYC is involved most commonly in human tumors.</li>\n<li>MYC oncogene is a transcription factor with a wide array of functions affecting cellular activities such as cell cycle, apoptosis, DNA damage response and hematopoiesis. Due to the multi-functionality of MYC, its expression is regulated at multiple levels. Myc is a family of regulator genes and proto-oncogenes that code for transcription factors.</li>\n<li>The Myc family consists of three related human genes: c-myc, l-myc and n-myc. c-myc was the first gene to be discovered in this family, due to homology with the viral gene v-myc.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<ul>\n<li><strong>Protein kinase inhibitor(Option A)</strong><strong>:</strong>A molecule that inhibits the activity of protein kinases, enzymes that add phosphate groups to proteins (phosphorylation), which is a key mechanism in signal transduction.</li>\n<li><strong>Examples</strong>:\n<ul>\n<li><strong>p21, p27</strong>: These are cyclin-dependent kinase inhibitors that halt the cell cycle.</li>\n<li><strong>Imatinib</strong>: A therapeutic kinase inhibitor used in CML (targets BCR-ABL).</li>\n</ul>\n</li>\n<li><strong>Growth factor inhibitor(Option B):</strong>A substance that inhibits the activity or signaling of growth factors (like EGF, VEGF) that stimulate cell division and survival.</li>\n<li><strong>Examples</strong>:\n<ul>\n<li><strong>Monoclonal antibodies like bevacizumab</strong> (anti-VEGF).</li>\n<li><strong>TGF-&beta;</strong> can act as a growth inhibitor in early carcinogenesis.</li>\n</ul>\n</li>\n<li><strong>GTPase(Option C):</strong>GTPases are enzymes that bind and hydrolyze GTP. They are involved in signal transduction (e.g., RAS family), vesicle trafficking, and cytoskeletal dynamics.</li>\n</ul>",
      "correct_choice_id": 124,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Myc</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">p53</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">RAS</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Rb</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following gene mutation is associated with Li Fraumeni syndrome?</span></p>",
      "unique_key": "DT1168077",
      "question_audio": null,
      "question_video": null,
      "map_id": 1168077,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Li-Fraumeni syndrome is most commonly associated with germline mutations in the TP53 gene, which encodes the p53 tumor suppressor protein.Loss of p53 function results in genomic instability and uncontrolled cell proliferation, leading to cancer development.</li>\n<li>Li-Fraumeni syndrome(LFS) is a rare autosomal dominant cancer predisposition syndrome associated with high risks for a diverse spectrum of childhood and adult-onset malignancies. The lifetime risk of cancer in individuals with LFS is &ge;70% for men and &ge;90% for women.</li>\n<li>Patients with the Li-Fraumeni syndrome have a 25-fold greater chance of developing a malignant tumour by 50 years of age compared with the general population.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<ul>\n<li><strong>MYC(Option A):</strong>It is an Oncogene and transcription activator, Promotes cell growth and proliferation and is overexpressed in cancers like <strong>Burkitt lymphoma</strong> (due to t(8;14) translocation).</li>\n<li><strong>RAS(Option C):</strong> It is an oncogene GTPase involved in signal transduction pathways that promote growth.Its mutations lead to constitutive activation, common in pancreatic, colon, and lung cancers.</li>\n<li><strong>Rb (Retinoblastoma protein)(Option D)</strong>:It is a Tumor suppressor that controls the G1/S checkpoint of the cell cycle. It is associated with Retinoblastoma, osteosarcoma, and others.</li>\n</ul>",
      "correct_choice_id": 132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Determination of the karyotype</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Diagnosis of benign neoplasms</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Determination of aneuploidy</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Distinguishing carcinoma from sarcoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 59-year-old woman has a firm mass with irregular borders felt in her left breast on a routine physical examination. A fine needle aspiration is performed and microscopic examination shows an infiltrating ductal carcinoma. A left mastectomy with axillary lymph node dissection is performed. A tissue sample of this neoplasm is submitted for analysis by flow cytometry. Which of the following does flow cytometric analysis most likely provide?</span></p>",
      "unique_key": "DT1168079",
      "question_audio": null,
      "question_video": null,
      "map_id": 1168079,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Flow cytometry is a technique that measures physical and chemical characteristics of cells or particles as they flow in a fluid stream through a beam of light (usually a laser). When used in tumor analysis, it can assess:\n<ul>\n<li>DNA content of tumor cells</li>\n<li>Cell cycle distribution</li>\n<li>Immunophenotyping (particularly useful in hematologic malignancies)</li>\n</ul>\n</li>\n<li>Aneuploidy is defined as a number of chromosomes that is not a multiple of the haploid state (multiple of 23).</li>\n<li>Aneuploidy is the presence of one or more extra chromosomes or the absence of one or more chromosomes. The risk of fetal aneuploidy rises with increasing maternal age. Because fetal aneuploidy can affect any pregnancy, all pregnant women should be offered screening.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<ul>\n<li><strong>Determination of the karyotype(Option A):</strong>Karyotyping is the visual examination of chromosomes under a microscope, often performed on metaphase chromosomes from dividing cells (e.g, bone marrow or amniotic fluid).The best technique for karyotyping is G-banding or FISH (fluorescence in situ hybridization).</li>\n<li><strong>Diagnosis of benign neoplasms(Option B):</strong>Benign tumors usually do not show significant aneuploidy or abnormal cell cycle features, so flow cytometry has limited diagnostic value in benign lesions.</li>\n<li><strong>Distinguishing carcinoma from sarcoma(Option D): </strong>The Carcinomas (epithelial origin) and sarcomas (mesenchymal origin) are distinguished using histopathology and immunohistochemical markers (e.g, cytokeratins for carcinoma, vimentin for sarcoma).</li>\n</ul>",
      "correct_choice_id": 143,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Anaplasia</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Desmoplasia</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Dysplasia</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Metaplasia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 52-year-old woman feels a lump in her right breast. Her physician palpates an irregular 3 cm mass that is not movable because it appears fixed to the overlying skin, which is retracted. A mastectomy is performed and the pathologist on sectioning the breast finds a 3 x 3.5 cm ovoid mass that does not have discrete borders, but appears to infiltrate into the surrounding fibrofatty breast stroma. The mass is firm, white and has a fibrous consistency. Which of the following features is most likely demonstrated by the gross appearance of this mass?</span></p>",
      "unique_key": "DT1168084",
      "question_audio": null,
      "question_video": null,
      "map_id": 1168084,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Malignant potential is revealed only by invasion into adjacent tissues or metastasis.</li>\n<li>The stroma carrying the blood supply is crucial to the growth of tumours but does not aid in the separation of benign from malignant ones.</li>\n<li>The amount of stromal connective tissue does, however, determine the consistency of a neoplasm.</li>\n<li>Certain cancers induce a dense, abundant fibrous stroma(desmoplasia), making them hard, so-called \"scirrhous tumors\".</li>\n<li>Desmoplasia is the result of increased synthesis of extracellular matrix proteins and collagen by stromal cells. It is considered to be a reaction and response of the host tissue against invasive cancer cells.[5] The biological relevance of the desmoplastic response to cancer is still unclear.</li>\n</ul>",
      "correct_choice_id": 152,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">p53</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Rb</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">c-abl</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">NF-1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 53-year-old man has had increasing fatigue for the past 6 months. On physical examination he has a palpable spleen tip. Laboratory studies show a WBC count of 189,000/microliter. The peripheral blood smear shows many mature and immature myeloid cells present. Cytogenetic analysis of cells obtained via bone marrow aspiration reveals a t(9:22) translocation. This translocation leads to formation of a hybrid gene that greatly increases tyrosine kinase activity. Which of the following genes is most likely translocated to cause these findings?</span></p>",
      "unique_key": "DT1168088",
      "question_audio": null,
      "question_video": null,
      "map_id": 1168088,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The above history shows organomegaly with increased WBC counts.</li>\n<li>Peripheral smear with mature, immature myeloid cells and t(9:22) translocation is a case of chronic myeloid leukemia.</li>\n<li>BCR-ABL fusion gene formation is an early, perhaps initiating, event that drives leukemogenesis.</li>\n<li>The crucial role of BCR-ABL in cancer has been confirmed by the dramatic clinical response of patients with chronic myeloid leukemia to BCR-ABL kinase inhibitors.</li>\n</ul>",
      "correct_choice_id": 163,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Carcinoid syndrome</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Cushing's syndrome</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypercalcemia</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Polycythaemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Squamous cell carcinoma of the lung is associated with which of the following paraneoplastic syndrome?</span></p>",
      "unique_key": "DT1168102",
      "question_audio": null,
      "question_video": null,
      "map_id": 1168102,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/2023121622837516-dff1-4f2c-beb0-74c72af65016.png\">",
      "correct_choice_id": 173,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Myasthenia Gravis</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary hypertrophic osteopathy</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Troussau's syndrome(venous thrombosis)</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Bronchogenic carcinoma is associated with which of the following paraneoplastic syndromes?</span></p>",
      "unique_key": "DT1168107",
      "question_audio": null,
      "question_video": null,
      "map_id": 1168107,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/20231216d413fc1a-a671-4b22-a0fc-aa8122002a17.png\">\n<p>Trousseau syndrome, also commonly referred to as Trousseau's sign of malignancy to avoid confusion with Trousseau's sign of latent tetany is a type of paraneoplastic syndrome caused by adenocarcinomas, predominantly gastric, pancreatic and pulmonary, presenting as recurrent and migrating episodes of thrombophlebitis.</p>",
      "correct_choice_id": 184,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Guinea worm</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Clonorchiasis</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Both of the above</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following parasitic infection predispose to malignancy?</span></p>",
      "unique_key": "DT1168115",
      "question_audio": null,
      "question_video": null,
      "map_id": 1168115,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Clonorchiasis is associated with cholangiocarcinoma.</li>\n<li>Clonorchiasis or Chinese liver fluke disease, is a foodborne trematode infection caused by trematode worms(also called flukes). It is caused by infection with Clonorchis sinensis. Adult C.sinensis flukes may measure up to 20 mm x 5 mm.</li>\n<li>Mechanism of Carcinogenesis is by Chronic inflammation of the biliary epithelium and Increased cell turnover and oxidative stress,Resulting in DNA damage and mutations</li>\n</ul>",
      "correct_choice_id": 192,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Neuroblastoma</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Neurofibroma</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Malignant melanoma</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Angiosarcoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">HMB-45 is tumour marker for?</span></p>",
      "unique_key": "DT1168118",
      "question_audio": null,
      "question_video": null,
      "map_id": 1168118,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>HMB-45 is present in melanosomes and is specific.</li>\n<li>Malignant melanoma express <strong>HMB 45, S-100 and Vimentin.</strong></li>\n<li>The most serious type of skin cancer. Melanoma occurs when the pigment-producing cells that give colour to the skin become cancerous.</li>\n<li>Symptoms might include a new, unusual growth or a chaange in an existing mole. Melanomas can occur anywhere on the body.</li>\n</ul>",
      "correct_choice_id": 203,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Is an inhibitor of G1/S transition</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibitor of cell adhesion, cell motility</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibitor of RAS/MAPK signalling</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Brings about DNA mismatch repair</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a mechanism for NF1 gene?</span></p>",
      "unique_key": "DT1172305",
      "question_audio": null,
      "question_video": null,
      "map_id": 1172305,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>NF1 is an autosomal dominant disorder caused by mutations in the tumor suppressor neurofibromin, encoded on the long arm of chromosome 17(17q). Neurofibromin is a negative regulator of the potent oncoprotein Ras(Chapter 6). Loss of neurofibromin function and the resulting Ras hyperactivity appear to be a cardinal feature of NF1- associated tumors. As would be anticipated for a tumor suppressor gene, the sole normal NF1 allele is mutated or silenced in tumors arising in the setting of NF1. These include neurofibromas of all three main types, malignant peripheral nerve sheath tumors, \"optic gliomas\" and other glial tumors. In addition, patients with NF1 exhibit learning disabilities, seizures, skeletal abnormalities, vascular abnormalities with arterial stenoses, pigmented nodules of the iris(Lisch nodules) and pigmented skin lesions(axillary freckling and cafe-au-lait spots) in various degrees.</li>\n<li>RAS most commonly is activated by point mutations in amino acid residues that are either within the GTP binding pocket or in the enzymatic region that carries out GTP hydrolysis. Both kinds of mutations interfere with breakdown of GTP, which is essential to inactivate RAS. RAS is thus trapped in its activated, GTP-bound form, and the cell is forced into a continuously proliferating state. It follows from this scenario that the consequences of activating mutations in RAS should be mimicked by loss-of-function mutations in GAPs, which would lead to a failure to simulate GTP hydrolysis and thereby restrain RAS. Indeed, the GAP neurofibromin-1(NF1) is mutated in the cancer-prone familial disorder neurofibromatosis type 1</li>\n</ul>",
      "correct_choice_id": 213,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Categorization of Undifferentiated Malignant Tumours</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Categorization of Leukaemias and Lymphomas</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Determination of Site of Origin of Metastatic Tumours</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What are the uses of immunohistochemistry in diagnosis of cancer?</span></p>",
      "unique_key": "DT1172322",
      "question_audio": null,
      "question_video": null,
      "map_id": 1172322,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/20231216564e67d0-c49c-4b56-8882-e01bfddaf8b4.png\">\n<p>Immunohistochemistry offers a powerful adjunct to routine histologic examination. Detection of cytokeratin by stains performed with specific monoclonal antibodies points to a diagnosis of undifferentiated carcinoma rather than large cell lymphoma. Similarly, detection of prostatespecific antigen(PSA) in metastatic deposits by immunohistochemical staining allows definitive diagnosis of a primary tumor in the prostate gland. Immunocytochemical detection of estrogen receptors allows prognostication and directs therapeutic intervention in breast cancers.</p>\n<p>Immunohistochemistry is the most common application of immunostaining. It involves the process of selectively identifying antigens in cells of a tissue section by exploiting the principle of antibodies binding specifically to antigens in biological tissues.</p>",
      "correct_choice_id": 224,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">The extent to which tumour cells resemble their normal mature tissues in structure</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">The extent to which tumour cells resemble primitive tissue of the fetus in function</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">The extent to which tumour cells resemble their normal mature tissue in structure and function</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">The extent to which tumour cells resemble primitive tissue of the fetus in structure and function</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is MOST suitable definition for Differentiation in context to Neoplasia?</span></p>",
      "unique_key": "DT1172324",
      "question_audio": null,
      "question_video": null,
      "map_id": 1172324,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Differentiation refers to the extent to which neoplasms resemble their parenchymal cells of origin, both morphologically and functionally; lack of differentiation is called anaplasia. In general, benign neoplasms are composed of well-differentiated cells that closely resemble their normal counterparts.</p>",
      "correct_choice_id": 233,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">p53</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Rb</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">PTEN</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">APC</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following tumour suppression gene mutation is associated with endometrial carcinoma?</span></p>",
      "unique_key": "DT1172326",
      "question_audio": null,
      "question_video": null,
      "map_id": 1172326,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Important tumor suppressor called PTEN is a negative inhibitor of PI3 kinase and is frequently mutated in carcinomas, certain leukemias and other cancers as well.</p>\n<p>Mutations in mismatch repair genes and the tumor suppressor gene PTEN are early events in the stepwise development of endometrioid carcinoma. Women with germline mutations in PTEN(Cowden Syndrome) and germline alterations in DNA mismatch repair genes(Lynch Syndrome) are at high risk for this cancer. TP53 mutations occur but are relatively uncommon and are late events in the genesis of this tumor type.</p>\n<p>The PTEN gene provides instructions for making an enzyme that is found in almost all tissues in the body. The enzyme acts as a tumor suppressor, which means that it helps regulate cell division by keeping cells from growing and dividing(proliferating) too rapidly or in an uncontrolled way.</p>",
      "correct_choice_id": 243,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 26,
      "choices": [
        {
          "id": 251,
          "text": "<p><span style=\"font-size:12.0pt;\">Autosomal recessive</span></p>"
        },
        {
          "id": 252,
          "text": "<p><span style=\"font-size:12.0pt;\">Autosomal dominant</span></p>"
        },
        {
          "id": 253,
          "text": "<p><span style=\"font-size:12.0pt;\">X-linked recessive</span></p>"
        },
        {
          "id": 254,
          "text": "<p><span style=\"font-size:12.0pt;\">X-linked dominant</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the inheritance pattern of Familial Retinoblastoma?</span></p>",
      "unique_key": "DT1172329",
      "question_audio": null,
      "question_video": null,
      "map_id": 1172329,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Inherited Predisposition to Cancer:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240326598171ad-7436-42ae-8443-37d835f8fc95.jpg.jpg\">\n<p>Hereditary retinoblastoma is passed from parents to children in an autosomal dominant pattern, which means only one parent needs a single copy of the mutated gene to pass the increased risk of retinoblastoma on to the children. If one parent carries a mutated gene, each child has a 50% chance of inheriting that gene.</p>",
      "correct_choice_id": 252,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 27,
      "choices": [
        {
          "id": 261,
          "text": "<p><span style=\"font-size:12.0pt;\">Only i, ii and iii are correct</span></p>"
        },
        {
          "id": 262,
          "text": "<p><span style=\"font-size:12.0pt;\">Only i and iii are correct</span></p>"
        },
        {
          "id": 263,
          "text": "<p><span style=\"font-size:12.0pt;\">Only ii and iv are correct</span></p>"
        },
        {
          "id": 264,
          "text": "<p><span style=\"font-size:12.0pt;\">Only iv is correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following protease/s is/are responsible for degradation of extracellular matrix?<br>i. Urokinase plasminogen<br>ii. Metalloproteases<br>iii. Cathepsin D<br>iv. Free radicals</span></p>",
      "unique_key": "DT1172334",
      "question_audio": null,
      "question_video": null,
      "map_id": 1172334,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Tumor cells may either secrete proteolytic enzymes themselves or induce stromal cells(e.g., fibroblasts and inflammatory cells) to elaborate proteases. Multiple different proteases, such as matrix metalloproteinases(MMPs), cathepsin D and urokinase plasminogen activator, have been implicated in tumor cell invasion.</li>\n<li>Human tissues are organized into a series of compartments separated from each other by two types of ECM: basement membranes and interstitial connective tissue. Although organized differently, each type of ECM is composed of collagens, glycoproteins, and proteoglycans.</li>\n<li>Tumor cells must interact with the ECM at several stages in the metastatic cascade. A carcinoma first must breach the underlying basement membrane, then traverse the interstitial connective tissue, and ultimately gain access to the circulation by penetrating the vascular basement membrane. This process is repeated in reverse when tumor cell emboli extravasate at a distant site. Invasion of the ECM initiates the metastatic cascade and is an active process.</li>\n</ul>",
      "correct_choice_id": 261,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 28,
      "choices": [
        {
          "id": 271,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleomorphism</span></p>"
        },
        {
          "id": 272,
          "text": "<p><span style=\"font-size:12.0pt;\">Atypia</span></p>"
        },
        {
          "id": 273,
          "text": "<p><span style=\"font-size:12.0pt;\">Invasion</span></p>"
        },
        {
          "id": 274,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased nuclear/cytoplasmic ratio</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pathologist is reviewing prostate biopsy specimens taken from patients with palpable rectal masses. Which of the following histologic features most reliably confirms that the lesion is malignant rather than benign?</span></p>",
      "unique_key": "DT1172337",
      "question_audio": null,
      "question_video": null,
      "map_id": 1172337,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Invasion through the basement membrane into surrounding stroma is the single most reliable microscopic feature distinguishing a malignant neoplasm from a benign one.</li>\n<li>Cellular atypia, pleomorphism, and a high nuclear-to-cytoplasmic ratio are suggestive of malignancy,they can also be seen in benign or dysplastic conditions.<strong>(Option A,B and D ruled out)</strong></li>\n<li>Invasion, and metastasis, the major causes of cancer-related morbidity and mortality, result from complex interactions involving cancer cells, stromal cells and the extracellular matrix(ECM).</li>\n<li>These interactions can be broken down into a series of steps consisting of local invasion, intravasation into blood and lymph vessels, transit through the vasculature, extravasation from the vessels, formation of micrometastases and growth of micrometastases into macroscopic tumors.</li>\n</ul>",
      "correct_choice_id": 273,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 29,
      "choices": [
        {
          "id": 281,
          "text": "<p><span style=\"font-size:12.0pt;\">Melanoma</span></p>"
        },
        {
          "id": 282,
          "text": "<p><span style=\"font-size:12.0pt;\">Papillary thyroid carcinoma</span></p>"
        },
        {
          "id": 283,
          "text": "<p><span style=\"font-size:12.0pt;\">Langerhans cell histiocytosis</span></p>"
        },
        {
          "id": 284,
          "text": "<p><span style=\"font-size:12.0pt;\">Ovarian carcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following tumors is least likely to harbor a BRAF V600E mutation and therefore is not typically considered a candidate for BRAF inhibitor therapy?</span></p>",
      "unique_key": "DT1172339",
      "question_audio": null,
      "question_video": null,
      "map_id": 1172339,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>BRAF mutations are extremely rare in ovarian carcinomas and thus the use of targeted BRAF inhibitor therapy is less defined.</li>\n<li>Therapies that directly target specific mutations are increasingly being developed, and thus detection of such mutations in a tumor can guide the development of targeted therapy.</li>\n<li>It is now becoming evident that certain targetable mutations transgress morphologic categories. One example involves a valine for glutamate substitution in amino acid 600(V600E) of the serine/threonine kinase BRAF, which you will recall lies downstream of RAS in the growth factor signaling pathway. \\</li>\n<li>Melanomas with the V600E BRAF mutation respond well to BRAF inhibitors, whereas melanomas without this mutation show no response.(<strong>Option A ruled out). </strong></li>\n<li>It is also seen that the same V600E mutation is also present in a subset of many other diverse cancers, including carcinomas of the colon and thyroid gland, most hairy cell leukemias, and many cases of Langerhans cell histiocytosis. These tumors are morphologically diverse and have distinct cells of origin, but they share identical oncogenic lesions in a common pro-growth pathway.<strong>(Option B&amp;Option C ruled out)</strong></li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/202312167945716c-2ca8-49ac-a65a-5b4027a3af51.png\">",
      "correct_choice_id": 284,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 30,
      "choices": [
        {
          "id": 291,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal cell carcinoma</span></p>"
        },
        {
          "id": 292,
          "text": "<p><span style=\"font-size:12.0pt;\">Carcinoma colon</span></p>"
        },
        {
          "id": 293,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatocellular carcinoma</span></p>"
        },
        {
          "id": 294,
          "text": "<p><span style=\"font-size:12.0pt;\">Testicular carcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following malignancies is considered the most radiosensitive, responding exceptionally well to radiotherapy?</span></p>",
      "unique_key": "DT1172341",
      "question_audio": null,
      "question_video": null,
      "map_id": 1172341,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Testicular carcinoma (especially seminoma) is one of the most radiosensitive tumors. Even low doses of radiation can lead to significant tumor shrinkage and cure in early-stage disease. This radiosensitivity is due to:\n<ul>\n<li>High proliferative activity</li>\n<li>Low DNA repair capacity</li>\n<li>Tumor cell type (germ cell tumors respond well)</li>\n</ul>\n</li>\n<li>Testicular cancers are often treated with orchiectomy followed by radiotherapy or chemotherapy, especially in seminomas.</li>\n<li>The exception is choriocarcinoma, which is associated with a poorer prognosis. With all testicular tumors, recurrences, typically in the form of distant metastases, usually occur within the first 2 years after treatment.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<ul>\n<li><strong>Renal cell carcinoma (RCC)(Option A):</strong>It is a highly radioresistant tumor.RCC does not respond well to radiotherapy; it's typically managed by surgery (nephrectomy)</li>\n<li><strong>Carcinoma colon(Option B):</strong>It is a moderately radioresistant cancer.Colon cancers are not primarily treated with radiation,Surgery remains the mainstay of treatment.</li>\n<li><strong>Hepatocellular carcinoma (HCC)(Option C):</strong>HCC is more commonly treated with:\n<ul>\n<li>Surgery (resection)</li>\n<li>Liver transplantation</li>\n<li>Ablation or embolization techniques</li>\n</ul>\n</li>\n<li>Radiotherapy is used in select cases but has limited effectiveness due to liver sensitivity.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/2023121649739d79-4fbf-455b-8ce1-441e6d05661b.png\">\n<p><strong>TESTICULAR CARCINOMA</strong></p>",
      "correct_choice_id": 294,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}